Cambridge Investment Research Advisors’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $777K | Sell |
12,342
-668
| -5% | -$46.7K | ﹤0.01% | 2543 |
|
|
2026
Q1 | $980K | Buy |
13,010
+24
| +0.2% | +$1.71K | ﹤0.01% | 2189 |
|
|
2025
Q4 | $802K | Buy |
12,986
+1,938
| +18% | +$114K | ﹤0.01% | 2290 |
|
|
2025
Q3 | $649K | Sell |
11,048
-4,497
| -29% | -$262K | ﹤0.01% | 2434 |
|
|
2025
Q2 | $905K | Sell |
15,545
-2,637
| -15% | -$149K | ﹤0.01% | 2032 |
|
|
2025
Q1 | $903K | Sell |
18,182
-778
| -4% | -$39.8K | ﹤0.01% | 1949 |
|
|
2024
Q4 | $848K | Buy |
18,960
+4,935
| +35% | +$234K | ﹤0.01% | 1999 |
|
|
2024
Q3 | $674K | Sell |
14,025
-1,328
| -9% | -$64K | ﹤0.01% | 2172 |
|
|
2024
Q2 | $782K | Sell |
15,353
-586
| -4% | -$32.1K | ﹤0.01% | 1946 |
|
|
2024
Q1 | $866K | Sell |
15,939
-246
| -2% | -$12.8K | ﹤0.01% | 1824 |
|
|
2023
Q4 | $912K | Sell |
16,185
-2,219
| -12% | -$125K | ﹤0.01% | 1708 |
|
|
2023
Q3 | $1.14M | Sell |
18,404
-4,620
| -20% | -$292K | 0.01% | 1481 |
|
|
2023
Q2 | $1.36M | Sell |
23,024
-2,005
| -8% | -$128K | 0.01% | 1404 |
|
|
2023
Q1 | $1.85M | Sell |
25,029
-5,253
| -17% | -$405K | 0.01% | 1173 |
|
|
2022
Q4 | $2.21M | Buy |
30,282
+2,055
| +7% | +$162K | 0.01% | 1025 |
|
|
2022
Q3 | $2.36M | Sell |
28,227
-9,655
| -25% | -$831K | 0.01% | 946 |
|
|
2022
Q2 | $3.01M | Sell |
37,882
-5,787
| -13% | -$562K | 0.02% | 846 |
|
|
2022
Q1 | $4.53M | Buy |
43,669
+23,279
| +114% | +$1.93M | 0.02% | 677 |
|
|
2021
Q4 | $1.53M | Buy |
20,390
+2,274
| +13% | +$159K | 0.01% | 1306 |
|
|
2021
Q3 | $1.18M | Buy |
18,116
+783
| +5% | +$47.9K | 0.01% | 1410 |
|
|
2021
Q2 | $1.05M | Buy |
17,333
+80
| +0.5% | +$4.73K | 0.01% | 1497 |
|
|
2021
Q1 | $930K | Buy |
17,253
+1,633
| +10% | +$88.8K | 0.01% | 1474 |
|
|
2020
Q4 | $751K | Sell |
15,620
-4,994
| -24% | -$221K | ﹤0.01% | 1489 |
|
|
2020
Q3 | $807K | Buy |
20,614
+3,785
| +22% | +$138K | 0.01% | 1309 |
|
|
2020
Q2 | $540K | Buy |
16,829
+95
| +0.6% | +$3.31K | ﹤0.01% | 1505 |
|
|
2020
Q1 | $567K | Sell |
16,734
-3,245
| -16% | -$130K | 0.01% | 1292 |
|
|
2019
Q4 | $957K | Sell |
19,979
-117
| -0.6% | -$5.65K | 0.01% | 1173 |
|
|
2019
Q3 | $1M | Buy |
20,096
+5,422
| +37% | +$277K | 0.01% | 1066 |
|
|
2019
Q2 | $784K | Sell |
14,674
-466
| -3% | -$24.3K | 0.01% | 1159 |
|
|
2019
Q1 | $799K | Sell |
15,140
-4,600
| -23% | -$240K | 0.01% | 1167 |
|
|
2018
Q4 | $928K | Buy |
19,740
+1,082
| +6% | +$56.4K | 0.01% | 967 |
|
|
2018
Q3 | $1.08M | Buy |
18,658
+522
| +3% | +$28.9K | 0.01% | 984 |
|
|
2018
Q2 | $986K | Sell |
18,136
-4,366
| -19% | -$217K | 0.01% | 989 |
|
|
2018
Q1 | $1.06M | Buy |
+22,502
| New | +$1.13M | 0.01% | 904 |
|
Other funds holding NTR
Cambridge Investment Research Advisors's NTR Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Nutrien (NTR) stake by 5.1% in Q2 2026, selling an estimated $46.7K and leaving 12,342 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #2543.
Cambridge Investment Research Advisors first reported a position in NTR in Q1 2018 and has held it in 34 quarters since. The position peaked at $4.53M in Q1 2022. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.
- Cambridge Investment Research Advisors held 12,342 shares of Nutrien worth $777K as of Q2 2026.
- Cambridge Investment Research Advisors sold 668 Nutrien shares in Q2 2026, an estimated $46.7K.
- Nutrien made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2543 holding.
- Cambridge Investment Research Advisors first reported a position in Nutrien in Q1 2018 and has held it in 34 quarters since.
- Cambridge Investment Research Advisors's Nutrien position peaked at $4.53M in Q1 2022.
- 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.